Type 2 diabetes mellitus, characterized by insulin resistance and impaired insulin secretion, has become a major public health concern due to lifestyle changes, urbanization, and aging populations
Movement Allodynia Pain felt with minor movements of the skin or muscles
Landmark analysis: a primer
Administration of Injections Semaglutide is administered via a once-weekly subcutaneous injection
The MHRA approved a higher 7.2 mg dose of Wegovy in January 2026, which gave an average weight loss of 20.7%, around 1 to 2 percentage points lower than Mounjaro 15 mg
Questions to Ask During Your Consultation Before committing to any treatment, it is reasonable to ask your doctor the following: Is this treatment approved by HSA for the purpose you are recommending it